杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/05/24 | 1,506 | 1,530 | 1,500 | 1,530 | +24 | +1.6% | 147,000 |
2011/05/23 | 1,493 | 1,514 | 1,484 | 1,506 | +13 | +0.9% | 215,000 |
2011/05/20 | 1,489 | 1,508 | 1,485 | 1,493 | -15 | -1% | 182,000 |
2011/05/19 | 1,488 | 1,516 | 1,480 | 1,508 | +20 | +1.3% | 294,000 |
2011/05/18 | 1,484 | 1,502 | 1,484 | 1,488 | +3 | +0.2% | 122,000 |
2011/05/17 | 1,484 | 1,491 | 1,479 | 1,485 | +9 | +0.6% | 171,000 |
2011/05/16 | 1,464 | 1,489 | 1,464 | 1,476 | -3 | -0.2% | 111,000 |
2011/05/13 | 1,506 | 1,506 | 1,473 | 1,479 | -19 | -1.3% | 129,000 |
2011/05/12 | 1,488 | 1,511 | 1,474 | 1,498 | +8 | +0.5% | 274,000 |
2011/05/11 | 1,500 | 1,500 | 1,471 | 1,490 | +3 | +0.2% | 149,000 |
2011/05/10 | 1,489 | 1,494 | 1,484 | 1,487 | ±0 | ±0% | 108,000 |
2011/05/09 | 1,494 | 1,501 | 1,483 | 1,487 | +3 | +0.2% | 199,000 |
2011/05/06 | 1,479 | 1,492 | 1,477 | 1,484 | +5 | +0.3% | 162,000 |
2011/05/02 | 1,449 | 1,485 | 1,445 | 1,479 | +34 | +2.4% | 211,000 |
2011/04/28 | 1,409 | 1,447 | 1,405 | 1,445 | +43 | +3.1% | 191,000 |
2011/04/27 | 1,405 | 1,415 | 1,388 | 1,402 | -3 | -0.2% | 198,000 |
2011/04/26 | 1,423 | 1,423 | 1,398 | 1,405 | -18 | -1.3% | 152,000 |
2011/04/25 | 1,452 | 1,455 | 1,419 | 1,423 | +1 | +0.1% | 168,000 |
2011/04/22 | 1,422 | 1,431 | 1,419 | 1,422 | +1 | +0.1% | 139,000 |
2011/04/21 | 1,422 | 1,426 | 1,413 | 1,421 | +1 | +0.1% | 99,000 |
2011/04/20 | 1,406 | 1,434 | 1,406 | 1,420 | +16 | +1.1% | 95,000 |
2011/04/19 | 1,401 | 1,414 | 1,400 | 1,404 | -16 | -1.1% | 98,000 |
2011/04/18 | 1,433 | 1,440 | 1,418 | 1,420 | -5 | -0.4% | 100,000 |
2011/04/15 | 1,415 | 1,432 | 1,410 | 1,425 | +15 | +1.1% | 193,000 |
2011/04/14 | 1,404 | 1,419 | 1,391 | 1,410 | +2 | +0.1% | 147,000 |
2011/04/13 | 1,398 | 1,414 | 1,398 | 1,408 | +8 | +0.6% | 54,000 |
2011/04/12 | 1,403 | 1,414 | 1,395 | 1,400 | -16 | -1.1% | 119,000 |
2011/04/11 | 1,415 | 1,424 | 1,397 | 1,416 | +18 | +1.3% | 231,000 |
2011/04/08 | 1,372 | 1,409 | 1,371 | 1,398 | +27 | +2% | 167,000 |
2011/04/07 | 1,370 | 1,388 | 1,364 | 1,371 | +3 | +0.2% | 233,000 |
2011/04/06 | 1,401 | 1,404 | 1,362 | 1,368 | -22 | -1.6% | 296,000 |
2011/04/05 | 1,406 | 1,408 | 1,379 | 1,390 | -9 | -0.6% | 154,000 |
2011/04/04 | 1,402 | 1,412 | 1,393 | 1,399 | -10 | -0.7% | 163,000 |
2011/04/01 | 1,422 | 1,430 | 1,401 | 1,409 | -7 | -0.5% | 181,000 |
2011/03/31 | 1,418 | 1,418 | 1,402 | 1,416 | +2 | +0.1% | 165,000 |
2011/03/30 | 1,388 | 1,414 | 1,381 | 1,414 | +16 | +1.1% | 207,000 |
2011/03/29 | 1,413 | 1,413 | 1,387 | 1,398 | -15 | -1.1% | 192,000 |
2011/03/28 | 1,436 | 1,436 | 1,400 | 1,413 | -12 | -0.8% | 131,000 |
2011/03/25 | 1,445 | 1,445 | 1,400 | 1,425 | +6 | +0.4% | 147,000 |
2011/03/24 | 1,381 | 1,421 | 1,372 | 1,419 | +25 | +1.8% | 255,000 |
2011/03/23 | 1,408 | 1,424 | 1,382 | 1,394 | -13 | -0.9% | 164,000 |
2011/03/22 | 1,396 | 1,407 | 1,390 | 1,407 | +41 | +3% | 160,000 |
2011/03/18 | 1,359 | 1,383 | 1,340 | 1,366 | +11 | +0.8% | 251,000 |
2011/03/17 | 1,260 | 1,369 | 1,250 | 1,355 | +35 | +2.7% | 314,000 |
2011/03/16 | 1,261 | 1,346 | 1,256 | 1,320 | +29 | +2.2% | 455,000 |
2011/03/15 | 1,372 | 1,372 | 1,220 | 1,291 | -111 | -7.9% | 339,000 |
2011/03/14 | 1,380 | 1,484 | 1,353 | 1,402 | -90 | -6% | 269,000 |
2011/03/11 | 1,493 | 1,510 | 1,486 | 1,492 | -17 | -1.1% | 271,000 |
2011/03/10 | 1,515 | 1,523 | 1,508 | 1,509 | -15 | -1% | 173,000 |
2011/03/09 | 1,516 | 1,539 | 1,507 | 1,524 | +9 | +0.6% | 271,000 |
3401~
3450
件表示中 / 3679件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 142,600円 | +3.2% | +4.5% | - | 16.39倍 | 0.69倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,700円 | +14.2% | +41.0% | - | 11.00倍 | 2.47倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 295,500円 | +3.0% | +27.5% | - | 18.71倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 181,600円 | +21.7% | +999.9% | 0.00% | 7.56倍 | 2.50倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,900円 | +0.4% | -8.4% | - | 27.46倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム